Bank of New York Mellon’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.78M | Buy |
410,552
+52,484
| +15% | +$611K | ﹤0.01% | 2280 |
|
|
2025
Q1 | $2.66M | Sell |
358,068
-5,838
| -2% | -$43.4K | ﹤0.01% | 2541 |
|
|
2024
Q4 | $2.18M | Sell |
363,906
-5,780
| -2% | -$34.7K | ﹤0.01% | 2714 |
|
|
2024
Q3 | $1.89M | Sell |
369,686
-90,446
| -20% | -$463K | ﹤0.01% | 2770 |
|
|
2024
Q2 | $1.67M | Buy |
460,132
+64,788
| +16% | +$235K | ﹤0.01% | 2897 |
|
|
2024
Q1 | $1.27M | Sell |
395,344
-19,638
| -5% | -$63K | ﹤0.01% | 3020 |
|
|
2023
Q4 | $2.03M | Buy |
414,982
+39,074
| +10% | +$191K | ﹤0.01% | 2826 |
|
|
2023
Q3 | $2.05M | Buy |
375,908
+2,325
| +0.6% | +$12.7K | ﹤0.01% | 2794 |
|
|
2023
Q2 | $2.51M | Sell |
373,583
-7,624
| -2% | -$51.2K | ﹤0.01% | 2710 |
|
|
2023
Q1 | $3.37M | Sell |
381,207
-10,356
| -3% | -$91.4K | ﹤0.01% | 2506 |
|
|
2022
Q4 | $2.99M | Sell |
391,563
-6,768
| -2% | -$51.7K | ﹤0.01% | 2622 |
|
|
2022
Q3 | $2.84M | Buy |
398,331
+18,897
| +5% | +$135K | ﹤0.01% | 2614 |
|
|
2022
Q2 | $3.07M | Sell |
379,434
-526,335
| -58% | -$4.26M | ﹤0.01% | 2593 |
|
|
2022
Q1 | $12.6M | Sell |
905,769
-23,418
| -3% | -$325K | ﹤0.01% | 1953 |
|
|
2021
Q4 | $26.1M | Sell |
929,187
-2,185
| -0.2% | -$61.3K | ﹤0.01% | 1562 |
|
|
2021
Q3 | $31.7M | Buy |
931,372
+25,869
| +3% | +$879K | 0.01% | 1448 |
|
|
2021
Q2 | $37M | Buy |
905,503
+33,928
| +4% | +$1.39M | 0.01% | 1363 |
|
|
2021
Q1 | $35.1M | Buy |
871,575
+4,042
| +0.5% | +$163K | 0.01% | 1361 |
|
|
2020
Q4 | $51.3M | Buy |
867,533
+83,916
| +11% | +$4.96M | 0.01% | 1035 |
|
|
2020
Q3 | $38.1M | Buy |
783,617
+77,282
| +11% | +$3.76M | 0.01% | 1067 |
|
|
2020
Q2 | $34.2M | Buy |
706,335
+562,170
| +390% | +$27.2M | 0.01% | 1118 |
|
|
2020
Q1 | $4.01M | Buy |
144,165
+101,849
| +241% | +$2.83M | ﹤0.01% | 2183 |
|
|
2019
Q4 | $1.27M | Buy |
42,316
+11,606
| +38% | +$347K | ﹤0.01% | 3107 |
|
|
2019
Q3 | $949K | Buy |
+30,710
| New | +$949K | ﹤0.01% | 3204 |
|